COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR
COVID-19 Booster Shots: What to Know About the Safety and Side Effects
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
F.D.A. Authorizes Updated Covid Booster Shots Targeting Omicron Subvariants - The New York Times
Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -
How much better are updated COVID boosters? Pfizer announces first results in human clinical trial - CBS News
NH COVID-19 Healthcare Provider and Public Health Partner Call
Boosters Work | CDC
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | NEJM
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study | The BMJ
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine | NEJM
What do people think about COVID-19 booster doses?, CCDR 48(7/8) - Canada.ca
Scanned Image
BNT162b2 Vaccine Booster and Mortality Due to Covid-19 | NEJM
Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM
Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine | Nature Communications
/cloudfront-us-east-1.images.arcpublishing.com/gray/FAEPGQZEJBEGVK6XZFLNEHQFF4.bmp "Health leaders discuss next steps after Johnson & Johnson releases booster shot study results")
Health leaders discuss next steps after Johnson & Johnson releases booster shot study results
First results of proton injection commissioning of the AGS Booster synchrotron - UNT Digital Library
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
KFF COVID-19 Vaccine Monitor: September 2022 | KFF
Your Questions about the New COVID Booster Shots, Answered - Scientific American
WIDeptHealthServices on Twitter: "Today's #COVID19_WI update, and a note. The 7-day average is no longer being affected by the backlog of results from external reporting sites. The number of new #COVID19 cases
